Organ transplantation using genetically modified farm animals

SOURCE www.npr.org
Revivicor Inc., a biotech company in Virginia, is using cloned farm animals to provide organs for transplantation. The company has genetically modified pigs with 10 modifications to ensure organ compatibility for transplants. The research aims to address the chronic shortage of organs for transplantation. There are ethical concerns and potential risks associated with using animal organs for human transplants.

Key Points

  • Revivicor Inc. is using cloned farm animals, specifically pigs, to provide organs for transplantation
  • The genetically modified pigs have 10 modifications to ensure organ compatibility for human transplants
  • The company aims to address the chronic shortage of organs for transplantation
  • Ethical concerns and potential risks are associated with using animal organs for human transplants

Pros

  • Potential solution to the chronic shortage of organs for transplantation
  • Genetically modified pigs could provide compatible organs for humans in need of transplants
  • Research has the potential to save many lives

Cons

  • Ethical concerns about using farm animals for organ transplantation
  • Risks of spreading animal viruses to humans
  • Questionable treatment of animals bred for organ harvesting